BROLUCIZUMAB

UNII: XSZ53G39H5
Preferred Substance Name: BROLUCIZUMAB

1531589-13-5
BEOVU
BROLUCIZUMAB [INN]
BROLUCIZUMAB [JAN]
BROLUCIZUMAB [MI]
BROLUCIZUMAB [USAN]
BROLUCIZUMAB [WHO-DD]
BROLUCIZUMAB DBLL [WHO-DD]
BROLUCIZUMAB-DBLL
ESBA1008
ESBA-1008
IMMUNOGLOBULIN, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ESBA1008 SCFV FRAGMENT)
RTH258
RTH-258

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

BROLUCIZUMAB

Synonyms and Mappings

Resources

Note